US Stock MarketDetailed Quotes

IPA ImmunoPrecise Antibodies

Watchlist

0.648
-0.022-3.34%

Close Sep 27 16:00 ET

0.650
+0.003+0.39%

Post 17:26 ET

18.08MMarket Cap-814P/E (TTM)

ImmunoPrecise Antibodies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jul 31, 2024

(FY)Apr 30, 2024

(Q4)Apr 30, 2024

(Q3)Jan 31, 2024

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

(Q2)Oct 31, 2022

Total revenue

-7.47%5.26M

18.65%24.52M

14.91%6.46M

20.31%6.22M

18.63%6.15M

21.31%5.69M

6.72%20.67M

7.29%5.62M

7.39%5.17M

9.78%5.18M

Operating revenue

-7.47%5.26M

18.65%24.52M

14.91%6.46M

20.31%6.22M

18.63%6.15M

21.31%5.69M

6.72%20.67M

7.29%5.62M

7.39%5.17M

9.78%5.18M

Cost of revenue

0.48%2.91M

36.95%12.47M

46.97%3.35M

37.02%3.02M

32.89%3.2M

30.90%2.89M

8.60%9.1M

18.56%2.28M

-0.99%2.21M

12.02%2.41M

Gross profit

-15.71%2.36M

4.24%12.05M

-6.97%3.11M

7.86%3.2M

6.30%2.95M

12.75%2.8M

5.28%11.56M

0.75%3.34M

14.62%2.96M

7.92%2.78M

Operating expense

6.43%6.98M

-30.56%25.82M

-2.33%6.62M

-13.09%6.54M

-43.71%5.96M

-46.58%6.56M

34.42%37.17M

-10.57%6.78M

9.70%7.52M

46.18%10.59M

Selling and administrative expenses

-3.35%4.88M

0.76%19.14M

9.81%5.03M

-2.45%4.83M

-9.01%4.23M

-3.88%5.05M

5.18%18.99M

-20.74%4.58M

14.19%4.95M

25.11%4.65M

-Selling and marketing expense

-32.46%718K

-1.80%3.54M

-2.68%909K

-22.37%649K

12.73%921K

4.01%1.06M

34.73%3.61M

8.10%934K

2.96%836K

41.84%817K

-General and administrative expense

4.41%4.16M

1.36%15.59M

13.00%4.12M

1.61%4.18M

-13.65%3.31M

-5.79%3.99M

0.04%15.38M

-25.81%3.65M

16.79%4.11M

22.05%3.83M

Research and development costs

73.39%1.64M

-71.33%4.04M

1.64%927K

-35.96%1M

-79.27%1.04M

-84.69%947K

84.01%14.1M

-31.12%912K

-24.05%1.56M

64.32%5M

Depreciation amortization depletion

-28.45%606K

-32.76%2.97M

-46.77%701K

-31.36%709K

-25.39%711K

-23.83%847K

119.27%4.41M

162.35%1.32M

105.78%1.03M

89.09%953K

-Depreciation and amortization

-28.45%606K

-32.76%2.97M

-46.77%701K

-31.36%709K

-25.39%711K

-23.83%847K

119.27%4.41M

162.35%1.32M

105.78%1.03M

89.09%953K

Other operating expenses

48.41%-146K

0.30%-331K

-23.08%-32K

----

-14.29%-16K

-4.81%-283K

-342.67%-332K

-36.84%-26K

38.89%-22K

26.32%-14K

Operating profit

-22.86%-4.63M

46.27%-13.76M

-2.18%-3.52M

26.72%-3.34M

61.50%-3.01M

61.58%-3.77M

-53.61%-25.61M

19.38%-3.44M

-6.72%-4.56M

-67.27%-7.81M

Net non-operating interest income expense

-125.00%-2K

-95.65%4K

-1,645.45%-340K

-105.13%-2K

477.78%208K

260.00%8K

-52.58%92K

-75.28%22K

-71.94%39K

357.14%36K

Non-operating interest income

----

-81.15%23K

-785.71%-336K

-92.31%3K

491.67%213K

--8K

-56.27%122K

-55.05%49K

-75.63%39K

500.00%36K

Non-operating interest expense

--2K

-36.67%19K

-85.19%4K

--5K

----

-64.71%30K

35.00%27K

--0

Other net income (expense)

-100.00%-146K

-569.28%-14.95M

-504.20%-14.97M

-51.32%-115K

-29.63%209K

-417.39%-73K

-453.88%-2.23M

-1,203.68%-2.48M

-114.79%-76K

318.38%297K

Gain on sale of security

-100.00%-146K

-62.11%86K

482.35%65K

-51.32%-115K

-29.63%209K

-417.39%-73K

-64.03%227K

91.05%-17K

-114.79%-76K

318.38%297K

Special income (charges)

----

-511.02%-15.03M

----

---2.46M

----

-Less:Impairment of capital assets

----

511.02%15.03M

----

--2.46M

----

Income before tax

-24.64%-4.78M

-3.43%-28.7M

-219.23%-18.82M

24.77%-3.46M

65.36%-2.59M

60.84%-3.83M

-75.11%-27.75M

-34.95%-5.9M

-27.00%-4.6M

-55.16%-7.48M

Income tax

-86.99%-776K

-28.02%-1.53M

-1.30%-777K

-597.12%-517K

125.40%32K

-2.98%-415K

-238.44%-1.19M

-378.91%-767K

-50.00%104K

-166.32%-126K

Net income

-17.07%-4M

-2.32%-27.18M

-251.82%-18.05M

37.43%-2.94M

64.33%-2.62M

63.59%-3.42M

-58.96%-26.56M

-10.44%-5.13M

-22.82%-4.7M

-46.76%-7.35M

Net income continuous Operations

-17.07%-4M

-2.32%-27.18M

-251.82%-18.05M

37.43%-2.94M

64.33%-2.62M

63.59%-3.42M

-58.96%-26.56M

-10.44%-5.13M

-22.82%-4.7M

-46.76%-7.35M

Minority interest income

Net income attributable to the parent company

-17.07%-4M

-2.32%-27.18M

-251.82%-18.05M

37.43%-2.94M

64.33%-2.62M

63.59%-3.42M

-58.96%-26.56M

-10.44%-5.13M

-22.82%-4.7M

-46.76%-7.35M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-17.07%-4M

-2.32%-27.18M

-251.82%-18.05M

37.43%-2.94M

64.33%-2.62M

63.59%-3.42M

-58.96%-26.56M

-10.44%-5.13M

-22.82%-4.7M

-46.76%-7.35M

Basic earnings per share

-7.14%-0.15

0.93%-1.06

-233.33%-0.7

42.11%-0.11

66.67%-0.1

63.16%-0.14

-25.88%-1.07

8.70%-0.21

5.00%-0.19

-15.38%-0.3

Diluted earnings per share

-7.14%-0.15

0.93%-1.06

-233.33%-0.7

42.11%-0.11

66.67%-0.1

63.16%-0.14

-25.88%-1.07

8.70%-0.21

5.00%-0.19

-15.38%-0.3

Dividend per share

Currency Unit

CAD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Jul 31, 2024	(FY)Apr 30, 2024	(Q4)Apr 30, 2024	(Q3)Jan 31, 2024	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023	(Q2)Oct 31, 2022
Total revenue	-7.47%5.26M	18.65%24.52M	14.91%6.46M	20.31%6.22M	18.63%6.15M	21.31%5.69M	6.72%20.67M	7.29%5.62M	7.39%5.17M	9.78%5.18M
Operating revenue	-7.47%5.26M	18.65%24.52M	14.91%6.46M	20.31%6.22M	18.63%6.15M	21.31%5.69M	6.72%20.67M	7.29%5.62M	7.39%5.17M	9.78%5.18M
Cost of revenue	0.48%2.91M	36.95%12.47M	46.97%3.35M	37.02%3.02M	32.89%3.2M	30.90%2.89M	8.60%9.1M	18.56%2.28M	-0.99%2.21M	12.02%2.41M
Gross profit	-15.71%2.36M	4.24%12.05M	-6.97%3.11M	7.86%3.2M	6.30%2.95M	12.75%2.8M	5.28%11.56M	0.75%3.34M	14.62%2.96M	7.92%2.78M
Operating expense	6.43%6.98M	-30.56%25.82M	-2.33%6.62M	-13.09%6.54M	-43.71%5.96M	-46.58%6.56M	34.42%37.17M	-10.57%6.78M	9.70%7.52M	46.18%10.59M
Selling and administrative expenses	-3.35%4.88M	0.76%19.14M	9.81%5.03M	-2.45%4.83M	-9.01%4.23M	-3.88%5.05M	5.18%18.99M	-20.74%4.58M	14.19%4.95M	25.11%4.65M
-Selling and marketing expense	-32.46%718K	-1.80%3.54M	-2.68%909K	-22.37%649K	12.73%921K	4.01%1.06M	34.73%3.61M	8.10%934K	2.96%836K	41.84%817K
-General and administrative expense	4.41%4.16M	1.36%15.59M	13.00%4.12M	1.61%4.18M	-13.65%3.31M	-5.79%3.99M	0.04%15.38M	-25.81%3.65M	16.79%4.11M	22.05%3.83M
Research and development costs	73.39%1.64M	-71.33%4.04M	1.64%927K	-35.96%1M	-79.27%1.04M	-84.69%947K	84.01%14.1M	-31.12%912K	-24.05%1.56M	64.32%5M
Depreciation amortization depletion	-28.45%606K	-32.76%2.97M	-46.77%701K	-31.36%709K	-25.39%711K	-23.83%847K	119.27%4.41M	162.35%1.32M	105.78%1.03M	89.09%953K
-Depreciation and amortization	-28.45%606K	-32.76%2.97M	-46.77%701K	-31.36%709K	-25.39%711K	-23.83%847K	119.27%4.41M	162.35%1.32M	105.78%1.03M	89.09%953K
Other operating expenses	48.41%-146K	0.30%-331K	-23.08%-32K	----	-14.29%-16K	-4.81%-283K	-342.67%-332K	-36.84%-26K	38.89%-22K	26.32%-14K
Operating profit	-22.86%-4.63M	46.27%-13.76M	-2.18%-3.52M	26.72%-3.34M	61.50%-3.01M	61.58%-3.77M	-53.61%-25.61M	19.38%-3.44M	-6.72%-4.56M	-67.27%-7.81M
Net non-operating interest income expense	-125.00%-2K	-95.65%4K	-1,645.45%-340K	-105.13%-2K	477.78%208K	260.00%8K	-52.58%92K	-75.28%22K	-71.94%39K	357.14%36K
Non-operating interest income	----	-81.15%23K	-785.71%-336K	-92.31%3K	491.67%213K	--8K	-56.27%122K	-55.05%49K	-75.63%39K	500.00%36K
Non-operating interest expense	--2K	-36.67%19K	-85.19%4K	--5K	--5K	----	-64.71%30K	35.00%27K	--0	--0
Other net income (expense)	-100.00%-146K	-569.28%-14.95M	-504.20%-14.97M	-51.32%-115K	-29.63%209K	-417.39%-73K	-453.88%-2.23M	-1,203.68%-2.48M	-114.79%-76K	318.38%297K
Gain on sale of security	-100.00%-146K	-62.11%86K	482.35%65K	-51.32%-115K	-29.63%209K	-417.39%-73K	-64.03%227K	91.05%-17K	-114.79%-76K	318.38%297K
Special income (charges)	----	-511.02%-15.03M	----	----	----	----	---2.46M	----	----	----
-Less:Impairment of capital assets	----	511.02%15.03M	----	----	----	----	--2.46M	----	----	----
Income before tax	-24.64%-4.78M	-3.43%-28.7M	-219.23%-18.82M	24.77%-3.46M	65.36%-2.59M	60.84%-3.83M	-75.11%-27.75M	-34.95%-5.9M	-27.00%-4.6M	-55.16%-7.48M
Income tax	-86.99%-776K	-28.02%-1.53M	-1.30%-777K	-597.12%-517K	125.40%32K	-2.98%-415K	-238.44%-1.19M	-378.91%-767K	-50.00%104K	-166.32%-126K
Net income	-17.07%-4M	-2.32%-27.18M	-251.82%-18.05M	37.43%-2.94M	64.33%-2.62M	63.59%-3.42M	-58.96%-26.56M	-10.44%-5.13M	-22.82%-4.7M	-46.76%-7.35M
Net income continuous Operations	-17.07%-4M	-2.32%-27.18M	-251.82%-18.05M	37.43%-2.94M	64.33%-2.62M	63.59%-3.42M	-58.96%-26.56M	-10.44%-5.13M	-22.82%-4.7M	-46.76%-7.35M
Minority interest income
Net income attributable to the parent company	-17.07%-4M	-2.32%-27.18M	-251.82%-18.05M	37.43%-2.94M	64.33%-2.62M	63.59%-3.42M	-58.96%-26.56M	-10.44%-5.13M	-22.82%-4.7M	-46.76%-7.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-17.07%-4M	-2.32%-27.18M	-251.82%-18.05M	37.43%-2.94M	64.33%-2.62M	63.59%-3.42M	-58.96%-26.56M	-10.44%-5.13M	-22.82%-4.7M	-46.76%-7.35M
Basic earnings per share	-7.14%-0.15	0.93%-1.06	-233.33%-0.7	42.11%-0.11	66.67%-0.1	63.16%-0.14	-25.88%-1.07	8.70%-0.21	5.00%-0.19	-15.38%-0.3
Diluted earnings per share	-7.14%-0.15	0.93%-1.06	-233.33%-0.7	42.11%-0.11	66.67%-0.1	63.16%-0.14	-25.88%-1.07	8.70%-0.21	5.00%-0.19	-15.38%-0.3
Dividend per share
Currency Unit	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data